Cargando…

Immunotherapy for liver tumors: present status and future prospects

Increasing evidence suggests that immune responses are involved in the control of cancer and that the immune system can be manipulated in different ways to recognize and attack tumors. Progress in immune-based strategies has opened new therapeutic avenues using a number of techniques destined to eli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matar, Pablo, Alaniz, Laura, Rozados, Viviana, Aquino, Jorge B, Malvicini, Mariana, Atorrasagasti, Catalina, Gidekel, Manuel, Silva, Marcelo, Scharovsky, O Graciela, Mazzolini, Guillermo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662798/ https://www.ncbi.nlm.nih.gov/pubmed/19272130 http://dx.doi.org/10.1186/1423-0127-16-30

Ejemplares similares

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
por: Malvicini, Mariana, et al.
Publicado: (2012)

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
por: Malvicini, Mariana, et al.
Publicado: (2012)

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
por: Fiore, Esteban, et al.
Publicado: (2016)

Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice
por: Atorrasagasti, Catalina, et al.
Publicado: (2013)

SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response
por: Peixoto, Estanislao, et al.
Publicado: (2016)

4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
por: Rodríguez, Marcelo M., et al.
Publicado: (2021)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Human Umbilical Cord Perivascular Cells Exhibited Enhanced Migration Capacity towards Hepatocellular Carcinoma in Comparison with Bone Marrow Mesenchymal Stromal Cells: A Role for Autocrine Motility Factor Receptor
por: Bayo, Juan, et al.
Publicado: (2014)

Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction
por: Rizzo, Manglio, et al.
Publicado: (2014)

Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma
por: Bayo, Juan, et al.
Publicado: (2014)

Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations
por: Atorrasagasti, Catalina, et al.
Publicado: (2021)

Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
por: Mazzolini, Guillermo, et al.
Publicado: (2020)

IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness
por: Bayo, Juan, et al.
Publicado: (2016)

Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models
por: Rico, María, et al.
Publicado: (2016)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)

A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting
por: Pagura, Lucas, et al.
Publicado: (2014)

Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition
por: Giúdice, Antonela Del, et al.
Publicado: (2020)

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Mazzolini, Guillermo, et al.
Publicado: (2018)

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2019)

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
por: Mainetti, Leandro E., et al.
Publicado: (2020)

Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice
por: Domínguez, Luciana M., et al.
Publicado: (2023)

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients
por: Onorato, Agostina M., et al.
Publicado: (2023)

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
por: Rosé, Adriana, et al.
Publicado: (2016)

Immunotherapy for Pemphigus: Present and Future
por: Yuan, Huijie, et al.
Publicado: (2022)

Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
por: Anselmino, L. E., et al.
Publicado: (2023)

Allergen Immunotherapy: Past, Present, and Future
por: Jutel, Marek, et al.
Publicado: (2016)

"Present and future of immunotherapy in Neuroendocrine Tumors"
por: Albertelli, Manuela, et al.
Publicado: (2021)

Allergen immunotherapy: past, present and future
por: Durham, Stephen R., et al.
Publicado: (2022)

Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017)

Past, present, and future of allergen immunotherapy vaccines
por: Dorofeeva, Yulia, et al.
Publicado: (2020)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Present status and future directions of intracanal medicaments
por: Ordinola‐Zapata, Ronald, et al.
Publicado: (2022)

Immunotherapy for hepatocellular carcinoma: current status and future perspectives
por: Okusaka, Takuji, et al.
Publicado: (2018)

Current Status of Immunotherapy for Lung Cancer and Future Perspectives
por: Kim, Ho Cheol, et al.
Publicado: (2020)

Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
por: Lu, Zhihao, et al.
Publicado: (2020)

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021)

Current Status and Future Directions of Bacteria-Based Immunotherapy
por: Tang, Quan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hvrt2s3qb0o9ct3nsjj66uds0b